IBDEI313 ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,48358,0)
 ;;=N50.812^^185^2420^101
 ;;^UTILITY(U,$J,358.3,48358,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,48358,1,3,0)
 ;;=3^Testicular Pain,Left
 ;;^UTILITY(U,$J,358.3,48358,1,4,0)
 ;;=4^N50.812
 ;;^UTILITY(U,$J,358.3,48358,2)
 ;;=^5138928
 ;;^UTILITY(U,$J,358.3,48359,0)
 ;;=N50.82^^185^2420^96
 ;;^UTILITY(U,$J,358.3,48359,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,48359,1,3,0)
 ;;=3^Scrotal Pain
 ;;^UTILITY(U,$J,358.3,48359,1,4,0)
 ;;=4^N50.82
 ;;^UTILITY(U,$J,358.3,48359,2)
 ;;=^5138930
 ;;^UTILITY(U,$J,358.3,48360,0)
 ;;=N52.35^^185^2420^36
 ;;^UTILITY(U,$J,358.3,48360,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,48360,1,3,0)
 ;;=3^Erectile Dysfunction Following Radiation Therapy
 ;;^UTILITY(U,$J,358.3,48360,1,4,0)
 ;;=4^N52.35
 ;;^UTILITY(U,$J,358.3,48360,2)
 ;;=^5138932
 ;;^UTILITY(U,$J,358.3,48361,0)
 ;;=N52.36^^185^2420^34
 ;;^UTILITY(U,$J,358.3,48361,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,48361,1,3,0)
 ;;=3^Erectile Dysfunction Following Interstitial Seed Therapy
 ;;^UTILITY(U,$J,358.3,48361,1,4,0)
 ;;=4^N52.36
 ;;^UTILITY(U,$J,358.3,48361,2)
 ;;=^5138933
 ;;^UTILITY(U,$J,358.3,48362,0)
 ;;=N52.37^^185^2420^35
 ;;^UTILITY(U,$J,358.3,48362,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,48362,1,3,0)
 ;;=3^Erectile Dysfunction Following Prostate Ablative Therapy
 ;;^UTILITY(U,$J,358.3,48362,1,4,0)
 ;;=4^N52.37
 ;;^UTILITY(U,$J,358.3,48362,2)
 ;;=^5138934
 ;;^UTILITY(U,$J,358.3,48363,0)
 ;;=R31.21^^185^2420^43
 ;;^UTILITY(U,$J,358.3,48363,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,48363,1,3,0)
 ;;=3^Hematuria,Asymptomatic Microscopic
 ;;^UTILITY(U,$J,358.3,48363,1,4,0)
 ;;=4^R31.21
 ;;^UTILITY(U,$J,358.3,48363,2)
 ;;=^5139198
 ;;^UTILITY(U,$J,358.3,48364,0)
 ;;=R31.29^^185^2420^44
 ;;^UTILITY(U,$J,358.3,48364,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,48364,1,3,0)
 ;;=3^Hematuria,Oth Microscopic
 ;;^UTILITY(U,$J,358.3,48364,1,4,0)
 ;;=4^R31.29
 ;;^UTILITY(U,$J,358.3,48364,2)
 ;;=^5019327
 ;;^UTILITY(U,$J,358.3,48365,0)
 ;;=R39.191^^185^2420^94
 ;;^UTILITY(U,$J,358.3,48365,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,48365,1,3,0)
 ;;=3^Re-Void,Immediate Need
 ;;^UTILITY(U,$J,358.3,48365,1,4,0)
 ;;=4^R39.191
 ;;^UTILITY(U,$J,358.3,48365,2)
 ;;=^5139199
 ;;^UTILITY(U,$J,358.3,48366,0)
 ;;=R39.192^^185^2420^60
 ;;^UTILITY(U,$J,358.3,48366,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,48366,1,3,0)
 ;;=3^Micturition,Position Dependent
 ;;^UTILITY(U,$J,358.3,48366,1,4,0)
 ;;=4^R39.192
 ;;^UTILITY(U,$J,358.3,48366,2)
 ;;=^5139200
 ;;^UTILITY(U,$J,358.3,48367,0)
 ;;=R39.198^^185^2420^59
 ;;^UTILITY(U,$J,358.3,48367,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,48367,1,3,0)
 ;;=3^Micturition,Oth Difficulties
 ;;^UTILITY(U,$J,358.3,48367,1,4,0)
 ;;=4^R39.198
 ;;^UTILITY(U,$J,358.3,48367,2)
 ;;=^5019347
 ;;^UTILITY(U,$J,358.3,48368,0)
 ;;=R39.82^^185^2420^11
 ;;^UTILITY(U,$J,358.3,48368,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,48368,1,3,0)
 ;;=3^Bladder Pain,Chronic
 ;;^UTILITY(U,$J,358.3,48368,1,4,0)
 ;;=4^R39.82
 ;;^UTILITY(U,$J,358.3,48368,2)
 ;;=^5139201
 ;;^UTILITY(U,$J,358.3,48369,0)
 ;;=T83.510A^^185^2420^48
 ;;^UTILITY(U,$J,358.3,48369,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,48369,1,3,0)
 ;;=3^Infection d/t Cystostomy Catheter,Init Encntr
 ;;^UTILITY(U,$J,358.3,48369,1,4,0)
 ;;=4^T83.510A
 ;;^UTILITY(U,$J,358.3,48369,2)
 ;;=^5140135
 ;;^UTILITY(U,$J,358.3,48370,0)
 ;;=T83.510D^^185^2420^50
